Cutting Edge: Leukotriene C4 Activates Mouse Platelets in Plasma Exclusively Through the Type 2 Cysteinyl Leukotriene Receptor

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2013 Nov 19

PMID 24244016

Citations 22

Authors

Hannah E Cummings

Tao Liu

Chunli Feng

Tanya M Laidlaw

Pamela B Conley

Yoshihide Kanaoka

Joshua A Boyce

Affiliations

Soon will be listed here.

Abstract

Leukotriene C4 (LTC4) and its extracellular metabolites, LTD4 and LTE4, mediate airway inflammation. They signal through three specific receptors (type 1 cys-LT receptor [CysLT1R], CysLT2R, and GPR99) with overlapping ligand preferences. In this article, we demonstrate that LTC4, but not LTD4 or LTE4, activates mouse platelets exclusively through CysLT2R. Platelets expressed CysLT1R and CysLT2R proteins. LTC4 induced surface expression of CD62P by wild-type mouse platelets in platelet-rich plasma (PRP) and caused their secretion of thromboxane A2 and CXCL4. LTC4 was fully active on PRP from mice lacking either CysLT1R or GPR99, but completely inactive on PRP from CysLT2R-null (Cysltr2(-/-)) mice. LTC4/CysLT2R signaling required an autocrine ADP-mediated response through P2Y12 receptors. LTC4 potentiated airway inflammation in a platelet- and CysLT2R-dependent manner. Thus, CysLT2R on platelets recognizes LTC4 with unexpected selectivity. Nascent LTC4 may activate platelets at a synapse with granulocytes before it is converted to LTD4, promoting mediator generation and the formation of leukocyte-platelet complexes that facilitate inflammation.

Citing Articles

Cysteinyl Leukotrienes in Allergic Inflammation.

Lee M, Boyce J, Barrett N Annu Rev Pathol. 2024; 20(1):115-141.

PMID: 39374430 PMC: 11759657. DOI: 10.1146/annurev-pathmechdis-111523-023509.

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.

Chen P, Wu M, He Y, Jiang B, He M Signal Transduct Target Ther. 2023; 8(1):237.

PMID: 37286535 PMC: 10244875. DOI: 10.1038/s41392-023-01510-8.

Bioactive lipid regulation of platelet function, hemostasis, and thrombosis.

Stanger L, Holinstat M Pharmacol Ther. 2023; 246:108420.

PMID: 37100208 PMC: 11143998. DOI: 10.1016/j.pharmthera.2023.108420.

Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung.

Saier L, Ribeiro J, Daunizeau T, Houssin A, Ichim G, Barette C Int J Mol Sci. 2022; 23(20).

PMID: 36293074 PMC: 9603002. DOI: 10.3390/ijms232012221.

Eicosanoids in inflammation in the blood and the vessel.

Yamaguchi A, Botta E, Holinstat M Front Pharmacol. 2022; 13:997403.

PMID: 36238558 PMC: 9551235. DOI: 10.3389/fphar.2022.997403.

References

Liu T, Laidlaw T, Katz H, Boyce J . Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A. 2013; 110(42):16987-92. PMC: 3801005. DOI: 10.1073/pnas.1313185110. View

Laidlaw T, Kidder M, Bhattacharyya N, Xing W, Shen S, Milne G . Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012; 119(16):3790-8. PMC: 3335383. DOI: 10.1182/blood-2011-10-384826. View

Maekawa A, Kanaoka Y, Lam B, Austen K . Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc Natl Acad Sci U S A. 2001; 98(5):2256-61. PMC: 30125. DOI: 10.1073/pnas.041624398. View

Momi S, Pitchford S, Alberti P, Minuz P, Del Soldato P, Gresele P . Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice. Thromb Haemost. 2005; 93(3):535-43. DOI: 10.1160/TH04-07-0464. View

Lam B, Penrose J, Freeman G, Austen K . Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci U S A. 1994; 91(16):7663-7. PMC: 44462. DOI: 10.1073/pnas.91.16.7663. View

Jiang Y, Borrelli L, Kanaoka Y, Bacskai B, Boyce J . CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood. 2007; 110(9):3263-70. PMC: 2200919. DOI: 10.1182/blood-2007-07-100453. View

Beller T, Maekawa A, Friend D, Austen K, Kanaoka Y . Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem. 2004; 279(44):46129-34. DOI: 10.1074/jbc.M407057200. View

Knorr B, Matz J, Bernstein J, Nguyen H, Seidenberg B, Reiss T . Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA. 1998; 279(15):1181-6. DOI: 10.1001/jama.279.15.1181. View

Hollopeter G, Jantzen H, Vincent D, Li G, ENGLAND L, Ramakrishnan V . Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001; 409(6817):202-7. DOI: 10.1038/35051599. View

10.

Han B, Luo G, Shi Z, Barrios R, Atwood D, Liu W . Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo. Am J Pathol. 2002; 161(2):481-90. PMC: 1850737. DOI: 10.1016/s0002-9440(10)64204-6. View

11.

Nonaka Y, Hiramoto T, Fujita N . Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem Biophys Res Commun. 2005; 337(1):281-8. DOI: 10.1016/j.bbrc.2005.09.052. View

12.

Gauvreau G, PARAMESWARAN K, Watson R, OByrne P . Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med. 2001; 164(8 Pt 1):1495-500. DOI: 10.1164/ajrccm.164.8.2102033. View

13.

Pitchford S, Momi S, Giannini S, Casali L, Spina D, Page C . Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood. 2004; 105(5):2074-81. DOI: 10.1182/blood-2004-06-2282. View

14.

Lee C, Lewis R, Corey E, Austen K . Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. Immunology. 1983; 48(1):27-35. PMC: 1453997. View

15.

Drazen J . Inhalation challenge with sulfidopeptide leukotrienes in human subjects. Chest. 1986; 89(3):414-9. DOI: 10.1378/chest.89.3.414. View

16.

Paruchuri S, Tashimo H, Feng C, Maekawa A, Xing W, Jiang Y . Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med. 2009; 206(11):2543-55. PMC: 2768854. DOI: 10.1084/jem.20091240. View

17.

Kanaoka Y, Boyce J . Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol. 2004; 173(3):1503-10. DOI: 10.4049/jimmunol.173.3.1503. View

18.

Hui Y, Yang G, Galczenski H, Figueroa D, Austin C, Copeland N . The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem. 2001; 276(50):47489-95. DOI: 10.1074/jbc.M107556200. View

19.

Maugeri N, Evangelista V, Celardo A, DellElba G, Martelli N, Piccardoni P . Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis. Thromb Haemost. 1994; 72(3):450-6. View

20.

Bubel S, Wilhelm D, Entelmann M, Kirchner H, Kluter H . Chemokines in stored platelet concentrates. Transfusion. 1996; 36(5):445-9. DOI: 10.1046/j.1537-2995.1996.36596282589.x. View